Literature DB >> 10225326

Survival of cancer patients in Finland 1955-1994.

P W Dickman1, T Hakulinen, T Luostarinen, E Pukkala, R Sankila, B Söderman, L Teppo.   

Abstract

INTRODUCTION: The study of survival of cancer patients is essential for monitoring the effectiveness of cancer control. The previous monograph describing cancer patient survival in Finland was published by the Finnish Cancer Registry in 1981 and covered patients diagnosed in 1953-1974. This new supplement assesses cancer patient survival up to the year 1995.
MATERIAL AND METHODS: The study includes over 560000 tumours registered at the Finnish Cancer Registry with a date of diagnosis between 1955 and 1994. Patients were followed up to the end of 1995. Trends in relative survival rates are studied over four 10-year diagnostic periods from 1955 to 1994. In addition, detailed results are presented for patients diagnosed during 1985-1994, including relative survival rates tabulated by stage, sex, and age. Additional sections describe differences in cancer patient survival according to social class and region of residence and a comparison of cancer patient survival in Finland to other European countries.
RESULTS: Patient survival improved over time for almost all anatomical sites. The main exception is in cancer of the cervix uteri, where patient survival has decreased slightly from 1965-1974 to 1985-1994 due to the selective prevention of less aggressive tumours through cytologic screening. Very few differences in patient survival are observed between males and females. A substantial improvement in survival can be seen for childhood cancers.
CONCLUSION: The increasing survival rates reflect improvements that have taken place in various areas of cancer control, from health education and early diagnosis to treatment and aftercare. This study provides valuable reference information for both clinicians and health administrators, as well as a baseline for more detailed studies of patient survival for individual anatomical sites.

Entities:  

Mesh:

Year:  1999        PMID: 10225326     DOI: 10.1080/028418699432996

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  16 in total

1.  Effect of intervention on decision making of treatment for disease progression, prostate-specific antigen biochemical failure and prostate cancer death.

Authors:  Rex C-C Huang; Anssi Auvinen; Matti Hakama; Teuvo L J Tammela; Martti Ala-Opas; Mikael Leppilahti; Timo Vornanen; Hsiu-Hsi Chen
Journal:  Health Expect       Date:  2012-07-19       Impact factor: 3.377

2.  Prognostic value of E2F1 in rectal cancer.

Authors:  Hasan Uzer; Hızır Akyıldız; Erdoğan Sözüer; Alper Akcan; Bahadır Öz
Journal:  Turk J Surg       Date:  2017-09-01

3.  Head and neck cancer in primary care: presenting symptoms and the effect of delayed diagnosis of cancer cases.

Authors:  Olli-Pekka Alho; Heikki Teppo; Pekka Mäntyselkä; Saara Kantola
Journal:  CMAJ       Date:  2006-03-14       Impact factor: 8.262

Review 4.  Critical windows of exposure for children's health: cancer in human epidemiological studies and neoplasms in experimental animal models.

Authors:  L M Anderson; B A Diwan; N T Fear; E Roman
Journal:  Environ Health Perspect       Date:  2000-06       Impact factor: 9.031

5.  Minimum follow-up time required for the estimation of statistical cure of cancer patients: verification using data from 42 cancer sites in the SEER database.

Authors:  Patricia Tai; Edward Yu; Gábor Cserni; Georges Vlastos; Melanie Royce; Ian Kunkler; Vincent Vinh-Hung
Journal:  BMC Cancer       Date:  2005-05-17       Impact factor: 4.430

6.  Population-based monitoring of cancer patient survival in situations with imperfect completeness of cancer registration.

Authors:  H Brenner; T Hakulinen
Journal:  Br J Cancer       Date:  2005-02-14       Impact factor: 7.640

7.  Calculating age-adjusted cancer survival estimates when age-specific data are sparse: an empirical evaluation of various methods.

Authors:  A Gondos; D M Parkin; E Chokunonga; H Brenner
Journal:  Br J Cancer       Date:  2006-02-13       Impact factor: 7.640

8.  Clinical practice guidelines in cancer: the European perspective.

Authors:  G Storme
Journal:  Br J Cancer       Date:  2001-05       Impact factor: 7.640

9.  Collagenase-2 (matrix metalloproteinase-8) plays a protective role in tongue cancer.

Authors:  J T Korpi; V Kervinen; H Mäklin; A Väänänen; M Lahtinen; E Läärä; A Ristimäki; G Thomas; M Ylipalosaari; P Aström; C Lopez-Otin; T Sorsa; S Kantola; E Pirilä; T Salo
Journal:  Br J Cancer       Date:  2008-02-05       Impact factor: 7.640

10.  Survival of patients with metastatic breast cancer: twenty-year data from two SEER registries.

Authors:  Patricia Tai; Edward Yu; Vincent Vinh-Hung; Gábor Cserni; Georges Vlastos
Journal:  BMC Cancer       Date:  2004-09-02       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.